Gefapixant is a selective P2X3 receptor antagonist utilized for the treatment of refractory or unexplained chronic cough in adults. This therapeutic agent works by inhibiting the P2X3 receptors located… Read more
Gefapixant is a selective P2X3 receptor antagonist utilized for the treatment of refractory or unexplained chronic cough in adults. This therapeutic agent works by inhibiting the P2X3 receptors located on sensory nerve fibers in the airway, which are associated with the cough reflex. To ensure precise analytical measurement and regulatory compliance, pharmaceutical laboratories utilize high-quality reference standards, including the active pharmaceutical ingredient itself, along with associated synthesis-related impurities and degradation products. These materials are essential for impurity profiling, method validation, and routine quality control testing. Furthermore, stable isotope labelled compounds are available as internal standards to facilitate accurate quantification using mass spectrometry-based techniques. These comprehensive resources support the rigorous characterization and batch consistency required throughout the drug development lifecycle and manufacturing processes.